Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Valenti

Showing results (21-30 of 438) with videos related to

Pageof 44
Sort By:
Science Bulletin|January 21, 2025
SLC7A11 transporter maintains critical nonessential amino acids levels to hamper ferroptosis during MASLD progressionElia Casirati, Luca Valenti
Lancet (London, England)|February 8, 2026
Once-monthly efimosfermin for non-cirrhotic MASHLuca Valenti, Giulia Periti
Journal of Hepatology|May 31, 2025
Bringing genetic testing into the clinical management of people with MASLD: Are we there yet?Luca Valenti, Hannes Hagström
PPAR Research|February 23, 2013
Peroxisome proliferator-activated receptor genetic polymorphisms and nonalcoholic Fatty liver disease: any role in disease susceptibility?Paola Dongiovanni, Luca Valenti
Journal of Hepatology|March 8, 2020
Update on NAFLD genetics: From new variants to the clinicEric Trépo, Luca Valenti
Hepatology (Baltimore, Md.)|July 12, 2016
Regulation of retinol-binding protein 4 and retinol metabolism in fatty liver diseaseStefano Romeo, Luca Valenti
Bioinformatics (Oxford, England)|October 17, 2017
myVCF: a desktop application for high-throughput mutations data managementAlessandro Pietrelli, Luca Valenti
Hepatobiliary Surgery and Nutrition|January 18, 2019
NGM282: a step forward in the nonalcoholic steatohepatitis treatment landscape?Luca Valenti, Valerio Nobili
International Journal of Molecular Sciences|July 18, 2017
A Nutrigenomic Approach to Non-Alcoholic Fatty Liver DiseasePaola Dongiovanni, Luca Valenti
Journal of Lipid Research|November 14, 2018
Beyond fat accumulation, NAFLD genetics converges on lipid droplet biologyGuido Baselli, Luca Valenti
Pageof 44

Showing results (21-30 of 438) with videos related to

Sort By:
Pageof 44
Science Bulletin|January 21, 2025
SLC7A11 transporter maintains critical nonessential amino acids levels to hamper ferroptosis during MASLD progressionElia Casirati, Luca Valenti
Lancet (London, England)|February 8, 2026
Once-monthly efimosfermin for non-cirrhotic MASHLuca Valenti, Giulia Periti
Journal of Hepatology|May 31, 2025
Bringing genetic testing into the clinical management of people with MASLD: Are we there yet?Luca Valenti, Hannes Hagström
PPAR Research|February 23, 2013
Peroxisome proliferator-activated receptor genetic polymorphisms and nonalcoholic Fatty liver disease: any role in disease susceptibility?Paola Dongiovanni, Luca Valenti
Journal of Hepatology|March 8, 2020
Update on NAFLD genetics: From new variants to the clinicEric Trépo, Luca Valenti
Hepatology (Baltimore, Md.)|July 12, 2016
Regulation of retinol-binding protein 4 and retinol metabolism in fatty liver diseaseStefano Romeo, Luca Valenti
Bioinformatics (Oxford, England)|October 17, 2017
myVCF: a desktop application for high-throughput mutations data managementAlessandro Pietrelli, Luca Valenti
Hepatobiliary Surgery and Nutrition|January 18, 2019
NGM282: a step forward in the nonalcoholic steatohepatitis treatment landscape?Luca Valenti, Valerio Nobili
International Journal of Molecular Sciences|July 18, 2017
A Nutrigenomic Approach to Non-Alcoholic Fatty Liver DiseasePaola Dongiovanni, Luca Valenti
Journal of Lipid Research|November 14, 2018
Beyond fat accumulation, NAFLD genetics converges on lipid droplet biologyGuido Baselli, Luca Valenti
Pageof 44